Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
China
Sponsor
Xijing Hospital of Digestive Diseases
Enrollment target
~226 participants
Started
April 2026
Primary completion
April 2028
Age range
18 Years – 85 Years
Last updated on clinicaltrials.gov in April 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Yongquan Shi, Ph.D
Xijing Hospital of Digestive Diseases